In agreement with previous research showing 40–60% loss of striatal dopaminergic innervations from substantia nigra in de novo PD patients, we found a significantly reduced DAT-SPECT signal in the striatum (Brooks, 1998; Lee et al., 2000; Isaias et al., 2007). This evidence concerns the gene SLC6A3 and Parkinson disease.